Company intelligence / Profile preview
BioRay Pharmaceutical Co., Ltd.
Shanghai, Shanghai, Chinabioraypharm.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
BioRay is a commercial-stage biopharmaceutical company based in China focused on discovering, developing, manufacturing, and commercializing novel antibody therapeutics for immune-mediated diseases and cancers. Its lead program is an ADC targeting ROR1-positive hematological malignancies and solid tumors using its proprietary CysX™ platform. The company also has marketed products and end-to-end capabilities from R&D to manufacturing. The Taiwan-based affiliate focuses on probiotics, immune cell products, health supplements, precision diagnostics/lab services, but does not appear to have late-stage drug assets.
- Therapeutic areas
- Oncology
- Modalities
- Monoclonal antibodiesAntibody-drug conjugates (ADCs)Probiotics and medicinal fungi
- Industry
- Biotech
02
Drug pipeline
10 assets9 more assets in the full pipeline.
Beyond the preview
Go deeper on BioRay Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioRay Pharmaceutical Co., Ltd..